Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK13 | O15264 | 11/20 | 0.64 |
| ▸ | MAPK12 | P53778 | 11/20 | 0.64 |
| ▸ | MAPK11 | Q15759 | 11/20 | 0.64 |
| ▸ | MAPK14 | Q16539 | 11/20 | 0.64 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5770799 | 0.94 | MAPK13 (0.66) | MAPK13MAPK12MAPK11MAPK14SOAT1 | |
| SCHEMBL5770323 | 0.93 | MAPK13 (0.66) | MAPK13MAPK12MAPK11MAPK14SOAT1 | |
| SCHEMBL5769876 | 0.92 | MAPK13 (0.65) | MAPK13MAPK12MAPK11MAPK14SOAT1 | |
| SCHEMBL5773326 | 0.92 | MAPK13 (0.65) | MAPK13MAPK12MAPK11MAPK14SOAT1 | |
| SCHEMBL5767640 | 0.86 | MAPK13 (0.69) | MAPK13MAPK12MAPK11MAPK14SOAT1 | |
| SCHEMBL5771864 | 0.86 | MAPK13 (0.70) | MAPK13MAPK12MAPK11MAPK14 | |
| SCHEMBL5768554 | 0.85 | MAPK14 (0.85) | MAPK13MAPK12MAPK11MAPK14 | |
| SCHEMBL5768798 | 0.85 | MAPK13 (0.76) | MAPK13MAPK12MAPK11MAPK14 | |
| SCHEMBL5768812 | 0.84 | MAPK14 (0.73) | MAPK13MAPK12MAPK11MAPK14 | |
| SCHEMBL5770997 | 0.84 | MAPK13 (0.63) | MAPK13MAPK12MAPK11MAPK14SOAT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6989395-B2 | Imidazolyl-cyclic acetals | AVENTIS PHARMA LIMITED (GB) | 2006-01-24 | — | — | US | disclosed |